Saturday 17 October 2026 Export NAGE’s income statement to Excel — free account

Niagen Bioscience, Inc.

Niagen Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.4 million, up 29.9% from fiscal 2024. In the quarter to June 2026, revenue fell 4.28%, EPS fell 80.0% and free cash flow grew 140.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

2.49 0.09 −3.49%

Follow NAGE

Alert me

Market cap: $204.2M
P/E: 12.5×
Fwd P/E: 15.0×
Dividend yield: —
F-score: 6/9
Altman Z: 10.54
Beneish M: −1.55
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	21.80%	27.07%	28.35%	38.90%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	5	6	7
ROA Full definition →	16.14%	19.05%	19.90%	26.42%
ROIC Full definition →	41.95%	51.81%	86.63%	188.93%
Return on Tangible Assets Full definition →	19.04%	22.29%	22.22%	28.22%
Average Days of Receivables Full definition →	24.26	36.57	27.47	24.90
Free Cash Flow per Share Full definition →	0.14	0.12	0.17	0.27
Free Cash Flow Full definition →	11.47	9.91	13.21	21.15
Capital Expenditures Full definition →	5.53	5.48	(0.29)	(0.26)
Other line items
Cash ROIC Full definition →	7.69%	6.65%	9.35%	15.67%
Accounts Receivable Turnover Full definition →	14.16	12.96	14.78	15.99
Accounts Payable Turnover Full definition →	3.99	3.90	4.79	4.58
Inventory Turnover Full definition →	2.63	2.65	3.12	3.07
Average Days of Payables Full definition →	74.63	104.03	85.23	103.29
Days of Inventory on Hand Full definition →	163.20	188.18	161.24	152.32
Tax Rate Full definition →	(0.06)	(0.05)	(0.04)	(0.02)
Research and Development Expense of Revenue Full definition →	5.03%	5.02%	4.89%	4.76%
Selling, General and Administrative Expense of Revenue Full definition →	52.53%	50.75%	48.34%	43.66%
Share Based Compensation of Revenue Full definition →	5.38%	5.14%	4.69%	4.07%
Operating CF/Net income Full definition →	0.37	0.24	0.78	1.05
Depreciation/Fixed assets Full definition →	0.78	0.68	0.59	0.52
Capex/Depreciation Full definition →	5.66	6.22	(0.37)	(0.34)
Revenue per Share Full definition →	1.63	1.63	1.63	1.56
Operating CF per Share Full definition →	0.08	0.06	0.17	0.27
Capex per Share Full definition →	0.07	0.07	0.00	0.00
Capex to Sales Full definition →	(0.04)	(0.04)	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly